(Q94538133)
Statements
A retrospective analysis of cardiovascular morbidity in metastatic hormone-refractory prostate cancer patients on high doses of the selective COX-2 inhibitor celecoxib (English)
R A Madan
Q Xia
R G Oriscello
scientific article published in July 2007
No description defined